805 844
transvaginal sonography. Ultrasound Obstet Gynecol 2015;46:
737–40
.
[65]
Guerriero S, Ajossa S, Minguez JA, et al. Accuracy of transvaginal ultrasound for diagnosis of deep endometriosis in uterosacral ligaments, rectovaginal septum, vagina and bladder: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2015;46: 534–45.
[66]
Thonnon C, Philip CA, Fassi-Fehri H, et al. Three-dimensional ultrasound in the management of bladder endometriosis. J Minim Invasive Gynecol 2015;22:403–9.[67]
Mallampati GK, Siegelman ES. MR imaging of the bladder. Magn Reson Imaging Clin N Am 2004;12:545–55.
[68]
Kruger K, Gilly L, Niedobitek-Kreuter G, Mpinou L, Ebert AD. Bladder endometriosis: characterization by magnetic resonance imaging and the value of documenting ureteral involvement. Eur J Obstet Gynecol Reprod Biol 2014;176:39–43.
[69]
Chamie LP, Blasbalg R, Goncalves MO, Carvalho FM, Abrao MS, de Oliveira IS. Accuracy of magnetic resonance imaging for diagnosis and preoperative assessment of deeply infiltrating endometriosis. Int J Gynaecol Obstet 2009;106:198–201.
[70]
Hottat N, Larrousse C, Anaf V, et al. Endometriosis: contribution of 3.0-T pelvic MR imaging in preoperative assessment—initial results. Radiology 2009;253:126–34.[71]
Bazot M, Gasner A, Lafont C, Ballester M, Darai E. Deep pelvic endometriosis: limited additional diagnostic value of postcontrast in comparison with conventional MR images. Eur J Radiol 2011;80:e331–9.
[72]
Kruger K, Behrendt K, Niedobitek-Kreuter G, Koltermann K, Ebert AD. Location-dependent value of pelvic MRI in the preoperative diagnosis of endometriosis. Eur J Obstet Gynecol Reprod Biol 2013;169:93–8.
[73]
Scardapane A, Lorusso F, Bettocchi S, et al. Deep pelvic endome- triosis: accuracy of pelvic MRI completed by MR colonography. Radiol Med 2013;118:323–38.
[74]
Di Paola V, Manfredi R, Castelli F, Negrelli R, Mehrabi S, Pozzi Mucelli R. Detection and localization of deep endometriosis by means of MRI and correlation with the ENZIAN score. Eur J Radiol 2015;84:568–74.
[75]
Medeiros LR, Rosa MI, Silva BR, et al. Accuracy of magnetic reso- nance in deeply infiltrating endometriosis: a systematic review and meta-analysis. Arch Gynecol Obstet 2015;291:611–21.
[76]
Vercellini P, Giudice LC, Evers JL, Abrao MS. Reducing low-value care in endometriosis between limited evidence and unresolved issues: a proposal. Hum Reprod 2015;30:1996–2004.[77]
Vercellini P, Carmignani L, Rubino T, Barbara G, Abbiati A, Fedele L. Surgery for deep endometriosis: a pathogenesis-oriented ap- proach. Gynecol obstet Investig 2009;68:88–103.
[78]
Serati M, Cattoni E, Braga A, Uccella S, Cromi A, Ghezzi F. Deep endometriosis and bladder and detrusor functions in women without urinary symptoms: a pilot study through an unexplored world. Fertil Steril 2013;100:1332–6.
[79]
de Lapasse C, Renouvel F, Chis C, Grosdemouge I, Panel P. [Urinary functional and urodynamic preoperative evaluation of patients with deep pelvic surgical endometriosis: about 12 cases]. Gynecol Obstet Fertil 2008;36:272–7.
[80]
Tafi E, Leone Roberti Maggiore U, Alessandri F, et al. Advances in pharmacotherapy for treating endometriosis. Expert Opin Phar- macother 2015;16:2465–83.
[81]
Ferrero S, Alessandri F, Racca A, Leone Roberti Maggiore U. Treat- ment of pain associated with deep endometriosis: alternatives and evidence. Fertil Steril 2015;104:771–92.
[82]
Vercellini P, Buggio L, Berlanda N, Barbara G, Somigliana E, Bosari S. Estrogen-progestins and progestins for the management of endometriosis. Fertil Steril 2016;106:1552–71.
[83]
Vercellini P, De Giorgi O, Oldani S, Cortesi I, Panazza S, Crosignani PG. Depot medroxyprogesterone acetate versus an oral contracep- tive combined with very-low-dose danazol for long-term treat- ment of pelvic pain associated with endometriosis. Am J Obstet Gynecol 1996;175:396–401.
[84]
Vercellini P, Pietropaolo G, De Giorgi O, Pasin R, Chiodini A, Crosignani PG. Treatment of symptomatic rectovaginal endome- triosis with an estrogen-progestogen combination versus low- dose norethindrone acetate. Fertil Steril 2005;84:1375–87.
[85]
Vercellini P, Barbara G, Somigliana E, Bianchi S, Abbiati A, Fedele L. Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis. Fertil Steril 2010;93:2150–61.
[86]
Fedele L, Bianchi S, Zanconato G, Portuese A, Raffaelli R. Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis. Fertil Steril 2001;75:485–8.
[87]
Ferrero S, Camerini G, Ragni N, Venturini PL, Biscaldi E, Remorgida V. Norethisterone acetate in the treatment of colorectal endome- triosis: a pilot study. Hum Reprod 2010;25:94–100.
[88]
Ferrero S, Leone Roberti Maggiore U, Scala C, Di Luca M, Venturini PL, Remorgida V. Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies. Arch Gynecol Obstet 2013;287:447–53.
[89]
Leone Roberti Maggiore U, Remorgida V, Scala C, Tafi E, Venturini PL, Ferrero S. Desogestrel-only contraceptive pill versus sequential contraceptive vaginal ring in the treatment of rectovaginal endo- metriosis infiltrating the rectum: a prospective open-label com- parative study. Acta Obstet Gynecol Scand 2014;93:239–47.
[90]
Walch K, Unfried G, Huber J, et al. Implanon versus medroxypro- gesterone acetate: effects on pain scores in patients with symptom- atic endometriosis—a pilot study. Contraception 2009;79:29–34.
[91]
Westney OL, Amundsen CL, McGuire EJ. Bladder endometriosis: conservative management. J Urol 2000;163:1814–7.
[92]
Fedele L, Bianchi S, Montefusco S, Frontino G, Carmignani L. A gonadotropin-releasing hormone agonist versus a continuous oral contraceptive pill in the treatment of bladder endometriosis. Fertil Steril 2008;90:183–4.
[93]
Ferrero S, Alessandri F, Racca A, Maggiore ULR. Treatment of pain associated with deep endometriosis: alternatives and evidence. Fertil Steril 2015;104:771–92.
[94]
Maccagnano C, Pellucchi F, Rocchini L, et al. Diagnosis and treat- ment of bladder endometriosis: state of the art. Urol Int 2012;89: 249–58.
[95]
Noe¨l JC, Chapron C, Bucella D, et al. Estrogen and progesterone receptors in smooth muscle component of deep infiltrating endo- metriosis. Fertil Steril 2010;93:1774–7.
[96]
Takagi H, Matsunami K, Ichigo S, Imai A. Novel [corrected] medical management of primary bladder endometriosis with dienogest: a case report. Clin Exp Obstet Gynecol 2011;38:184–5.
[97]
Harada M, Osuga Y, Izumi G, et al. Dienogest, a new conservative strategy for extragenital endometriosis: a pilot study. Gynecol Endocrinol 2011;27:717–20.
[98]
Agarwal A, Rathi S, Patnaik P, et al. Does preoperative urodynamic testing improve surgical outcomes in patients undergoing the transobturator tape procedure for stress urinary incontinence?. A prospective randomized trial. Korean J Urol 2014;55:821–7.
[99]
Angioni S, Nappi L, Pontis A, et al. Dienogest. A possible conserva- tive approach in bladder endometriosis. Results of a pilot study. Gynecol Endocrinol 2015;31:406–8.
[100]
Mousa NA, Bedaiwy MA, Casper RF. Aromatase inhibitors in the treatment of severe endometriosis. Obstet Gynecol 2007;109: 1421–3.[101]
Ferrero S, Biscaldi E, Luigi Venturini P, Remorgida V. Aromatase inhibitors in the treatment of bladder endometriosis. Gynecol Endocrinol 2011;27:337–40.E U R O P E A N U R O L O G Y 7 1 ( 2 0 1 7 ) 7 9 0 – 8 0 7
805